Industry News

EPAX Heads into Condition-Specific Markets

May 1, 2006

EPAX Heads into Condition-Specific Markets
EPAX, Lysaker, Norway, recently broke away from its parent company to concentrate on the business-to-business segment with its concentrated omega 3 EPA/DHA oils. While its former parent company, Pronova, focuses on the pharmaceutical market, EPAX will target supplement, and eventually food and beverage companies with its omega 3 fatty acid product lines. According to Gunilla Traberg, marketing manager, this development allows the company to move into more specific product application areas. “We are interested in going after specific health areas like mood health, cognitive support and heart and joint health,” she said. “The previous focus on wellness was too vague and commodity-based.” The company is also busy on the research front. In fact, EPAX 1050 is currently being studied in Alzheimer’s patients in a hospital in Stockholm, Sweden. In addition, the company has been hard at work developing and promoting its technology for cleaning and purifying its fish oils. Because of this, EPAX can guarantee much lower levels of mercury and PCBs in its products.

Related Health Conditions:

  • Delivery Trends for Ingredient Platforms on the Rise

    Delivery Trends for Ingredient Platforms on the Rise

    Stan Glab & Missy Lowery, Senior Formulator & Senior Manager, Marketing, Capsugel||October 3, 2016
    Creative hard capsule technologies demonstrate how dosage delivery forms matter.

  • Fortifying Women’s Health

    Fortifying Women’s Health

    Lisa Olivo, Associate Editor||May 2, 2016
    From pregnancy to PMS to menopause and more, women are turning to natural products to protect and preserve their health.

  • Healthy Immunity Through Stress Reduction

    Healthy Immunity Through Stress Reduction

    Lisa Schofield, Contributing Writer||January 5, 2016
    Addressing chronic stress and anxiety can have a significant effect on the immune system.